Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.

A visualisation showing a map with number of COVID-19 cases around the world

Maria Cobo, a DPhil student with the Paediatric Neuroimaging Group, is part of the Open COVID-19 Data Working Group, a response project coordinated by the Department of Zoology and the Oxford Martin School. It is an international team of volunteers curating data sources by hand and compiling the data in a standardised format. Uniquely, this format presents epidemiological data at an individual case level, which allows the extraction of detailed information on case demographics, travel histories and high resolution geographical distribution.

The cumulative results are updated daily, and can be viewed here: https://www.healthmap.org/covid-19/

Data fuelling the project are openly accessible here: https://github.com/beoutbreakprepared/nCoV2019/tree/master/latest_data

The description of the database and methods used was recently published in Scientific Data.

If you would like to take part in the project, please get in touch with Maria Cobo.

 

Funding for Oxford’s COVID-19 research requires unprecedented speed, scope and ambition. If you would like to support this work, please make a gift  >>

Similar stories

It’s not just Covid: the triple threat that could overwhelm the NHS this winter - Andrew Pollard

A severe flu outbreak or new coronavirus variant could prove catastrophic for a health service already on its knees

Study raises hope of pre-school type 1 diabetes screening programme

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.